Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9ADF5
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 13 |
GO:0006793 | phosphorus metabolic process | 3 | 13 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 13 |
GO:0006807 | nitrogen compound metabolic process | 2 | 13 |
GO:0007165 | signal transduction | 2 | 3 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0009987 | cellular process | 1 | 13 |
GO:0016310 | phosphorylation | 5 | 13 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 3 |
GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
GO:0018209 | peptidyl-serine modification | 6 | 3 |
GO:0019538 | protein metabolic process | 3 | 13 |
GO:0036211 | protein modification process | 4 | 13 |
GO:0043170 | macromolecule metabolic process | 3 | 13 |
GO:0043412 | macromolecule modification | 4 | 13 |
GO:0044237 | cellular metabolic process | 2 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0050794 | regulation of cellular process | 3 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 13 |
GO:0006810 | transport | 3 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 13 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0004672 | protein kinase activity | 3 | 13 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 8 |
GO:0005488 | binding | 1 | 13 |
GO:0005524 | ATP binding | 5 | 13 |
GO:0016301 | kinase activity | 4 | 13 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 13 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 13 |
GO:0017076 | purine nucleotide binding | 4 | 13 |
GO:0030554 | adenyl nucleotide binding | 5 | 13 |
GO:0032553 | ribonucleotide binding | 3 | 13 |
GO:0032555 | purine ribonucleotide binding | 4 | 13 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 13 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 13 |
GO:0036094 | small molecule binding | 2 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043168 | anion binding | 3 | 13 |
GO:0097159 | organic cyclic compound binding | 2 | 13 |
GO:0097367 | carbohydrate derivative binding | 2 | 13 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 13 |
GO:1901265 | nucleoside phosphate binding | 3 | 13 |
GO:1901363 | heterocyclic compound binding | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 354 | 358 | PF00656 | 0.478 |
CLV_C14_Caspase3-7 | 410 | 414 | PF00656 | 0.432 |
CLV_C14_Caspase3-7 | 486 | 490 | PF00656 | 0.609 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.369 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.309 |
CLV_NRD_NRD_1 | 327 | 329 | PF00675 | 0.360 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.369 |
CLV_PCSK_KEX2_1 | 327 | 329 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 361 | 363 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 361 | 363 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 384 | 388 | PF00082 | 0.441 |
CLV_TASPASE1 | 487 | 493 | PF01112 | 0.606 |
DOC_CKS1_1 | 309 | 314 | PF01111 | 0.388 |
DOC_PP4_FxxP_1 | 540 | 543 | PF00568 | 0.634 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 427 | 431 | PF00917 | 0.754 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.630 |
DOC_WW_Pin1_4 | 308 | 313 | PF00397 | 0.388 |
DOC_WW_Pin1_4 | 526 | 531 | PF00397 | 0.775 |
DOC_WW_Pin1_4 | 538 | 543 | PF00397 | 0.561 |
DOC_WW_Pin1_4 | 550 | 555 | PF00397 | 0.702 |
LIG_14-3-3_CanoR_1 | 130 | 138 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 236 | 240 | PF00244 | 0.355 |
LIG_14-3-3_CanoR_1 | 313 | 318 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 352 | 356 | PF00244 | 0.309 |
LIG_14-3-3_CanoR_1 | 97 | 101 | PF00244 | 0.486 |
LIG_Actin_WH2_2 | 339 | 354 | PF00022 | 0.309 |
LIG_Actin_WH2_2 | 399 | 414 | PF00022 | 0.450 |
LIG_BIR_III_2 | 524 | 528 | PF00653 | 0.649 |
LIG_BIR_III_4 | 511 | 515 | PF00653 | 0.629 |
LIG_BRCT_BRCA1_1 | 105 | 109 | PF00533 | 0.504 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.494 |
LIG_BRCT_BRCA1_1 | 288 | 292 | PF00533 | 0.388 |
LIG_eIF4E_1 | 336 | 342 | PF01652 | 0.388 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.464 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.380 |
LIG_FHA_1 | 437 | 443 | PF00498 | 0.529 |
LIG_FHA_1 | 476 | 482 | PF00498 | 0.595 |
LIG_FHA_2 | 466 | 472 | PF00498 | 0.674 |
LIG_FHA_2 | 97 | 103 | PF00498 | 0.492 |
LIG_Integrin_isoDGR_2 | 181 | 183 | PF01839 | 0.309 |
LIG_IRF3_LxIS_1 | 347 | 354 | PF10401 | 0.309 |
LIG_LIR_Gen_1 | 238 | 246 | PF02991 | 0.388 |
LIG_LIR_Gen_1 | 311 | 321 | PF02991 | 0.388 |
LIG_LIR_Gen_1 | 398 | 408 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 106 | 112 | PF02991 | 0.503 |
LIG_LIR_Nem_3 | 238 | 243 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 311 | 317 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 381 | 386 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 398 | 404 | PF02991 | 0.439 |
LIG_LYPXL_S_1 | 26 | 30 | PF13949 | 0.630 |
LIG_LYPXL_yS_3 | 27 | 30 | PF13949 | 0.630 |
LIG_MYND_1 | 24 | 28 | PF01753 | 0.618 |
LIG_NRBOX | 403 | 409 | PF00104 | 0.446 |
LIG_NRP_CendR_1 | 557 | 560 | PF00754 | 0.636 |
LIG_PCNA_yPIPBox_3 | 205 | 218 | PF02747 | 0.348 |
LIG_Pex14_2 | 94 | 98 | PF04695 | 0.534 |
LIG_PTB_Apo_2 | 302 | 309 | PF02174 | 0.348 |
LIG_SH2_CRK | 314 | 318 | PF00017 | 0.388 |
LIG_SH2_CRK | 401 | 405 | PF00017 | 0.444 |
LIG_SH2_PTP2 | 336 | 339 | PF00017 | 0.348 |
LIG_SH2_SRC | 261 | 264 | PF00017 | 0.388 |
LIG_SH2_STAP1 | 389 | 393 | PF00017 | 0.495 |
LIG_SH2_STAT3 | 208 | 211 | PF00017 | 0.348 |
LIG_SH2_STAT3 | 48 | 51 | PF00017 | 0.672 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.441 |
LIG_SH2_STAT5 | 336 | 339 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 340 | 343 | PF00017 | 0.380 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.690 |
LIG_SH3_3 | 306 | 312 | PF00018 | 0.309 |
LIG_SH3_3 | 524 | 530 | PF00018 | 0.622 |
LIG_SH3_3 | 536 | 542 | PF00018 | 0.559 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.665 |
LIG_SUMO_SIM_anti_2 | 215 | 221 | PF11976 | 0.450 |
LIG_SUMO_SIM_par_1 | 241 | 247 | PF11976 | 0.324 |
LIG_TYR_ITIM | 334 | 339 | PF00017 | 0.337 |
LIG_UBA3_1 | 169 | 176 | PF00899 | 0.474 |
LIG_WW_1 | 24 | 27 | PF00397 | 0.675 |
MOD_CDK_SPK_2 | 308 | 313 | PF00069 | 0.388 |
MOD_CDK_SPK_2 | 526 | 531 | PF00069 | 0.612 |
MOD_CDK_SPxxK_3 | 550 | 557 | PF00069 | 0.664 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.388 |
MOD_CK1_1 | 420 | 426 | PF00069 | 0.652 |
MOD_CK1_1 | 500 | 506 | PF00069 | 0.731 |
MOD_CK2_1 | 411 | 417 | PF00069 | 0.492 |
MOD_CK2_1 | 465 | 471 | PF00069 | 0.663 |
MOD_Cter_Amidation | 181 | 184 | PF01082 | 0.309 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.515 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.339 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.716 |
MOD_GlcNHglycan | 348 | 351 | PF01048 | 0.362 |
MOD_GlcNHglycan | 429 | 432 | PF01048 | 0.747 |
MOD_GlcNHglycan | 481 | 484 | PF01048 | 0.651 |
MOD_GlcNHglycan | 518 | 521 | PF01048 | 0.723 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.353 |
MOD_GSK3_1 | 304 | 311 | PF00069 | 0.455 |
MOD_GSK3_1 | 407 | 414 | PF00069 | 0.438 |
MOD_GSK3_1 | 416 | 423 | PF00069 | 0.529 |
MOD_GSK3_1 | 475 | 482 | PF00069 | 0.681 |
MOD_GSK3_1 | 496 | 503 | PF00069 | 0.631 |
MOD_GSK3_1 | 516 | 523 | PF00069 | 0.597 |
MOD_N-GLC_1 | 304 | 309 | PF02516 | 0.448 |
MOD_N-GLC_1 | 427 | 432 | PF02516 | 0.603 |
MOD_N-GLC_1 | 442 | 447 | PF02516 | 0.476 |
MOD_N-GLC_1 | 520 | 525 | PF02516 | 0.653 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.658 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.388 |
MOD_NEK2_1 | 239 | 244 | PF00069 | 0.365 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.328 |
MOD_NEK2_1 | 321 | 326 | PF00069 | 0.356 |
MOD_NEK2_1 | 407 | 412 | PF00069 | 0.461 |
MOD_NEK2_1 | 496 | 501 | PF00069 | 0.771 |
MOD_NEK2_2 | 235 | 240 | PF00069 | 0.365 |
MOD_OFUCOSY | 409 | 415 | PF10250 | 0.400 |
MOD_PIKK_1 | 47 | 53 | PF00454 | 0.836 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.504 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.372 |
MOD_PKA_2 | 351 | 357 | PF00069 | 0.321 |
MOD_PKA_2 | 411 | 417 | PF00069 | 0.456 |
MOD_PKA_2 | 500 | 506 | PF00069 | 0.630 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.496 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.514 |
MOD_Plk_1 | 304 | 310 | PF00069 | 0.348 |
MOD_Plk_1 | 368 | 374 | PF00069 | 0.398 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.514 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.344 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.348 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.538 |
MOD_ProDKin_1 | 308 | 314 | PF00069 | 0.388 |
MOD_ProDKin_1 | 526 | 532 | PF00069 | 0.773 |
MOD_ProDKin_1 | 538 | 544 | PF00069 | 0.565 |
MOD_ProDKin_1 | 550 | 556 | PF00069 | 0.703 |
MOD_SUMO_for_1 | 126 | 129 | PF00179 | 0.465 |
MOD_SUMO_for_1 | 366 | 369 | PF00179 | 0.392 |
MOD_SUMO_rev_2 | 141 | 150 | PF00179 | 0.461 |
TRG_DiLeu_BaEn_1 | 117 | 122 | PF01217 | 0.422 |
TRG_DiLeu_BaEn_1 | 279 | 284 | PF01217 | 0.388 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.630 |
TRG_ENDOCYTIC_2 | 314 | 317 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 336 | 339 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 401 | 404 | PF00928 | 0.384 |
TRG_ER_diArg_1 | 342 | 345 | PF00400 | 0.328 |
TRG_NES_CRM1_1 | 212 | 225 | PF08389 | 0.309 |
TRG_NES_CRM1_1 | 279 | 294 | PF08389 | 0.388 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKB0 | Leptomonas seymouri | 61% | 99% |
A0A0S4IVY6 | Bodo saltans | 29% | 100% |
A0A3Q8ISA0 | Leishmania donovani | 32% | 100% |
A0A3S7X0V1 | Leishmania donovani | 94% | 99% |
A4HFV0 | Leishmania braziliensis | 77% | 100% |
A4HIT6 | Leishmania braziliensis | 32% | 100% |
A4I2Y4 | Leishmania infantum | 94% | 99% |
A4I638 | Leishmania infantum | 32% | 100% |
E9AZ78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 99% |
E9B1C3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
Q4Q6U1 | Leishmania major | 31% | 100% |